Sarepta Therapeutics Inc (NASDAQ: SRPT) started the day on Wednesday, with a price increase of 6.09% at $124.25, before settling in for the price of $117.12 at the close. Taking a more long-term approach, SRPT posted a 52-week range of $55.25-$159.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 32.89%. Meanwhile, its Annual Earning per share during the time was -1.21%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 140.46%. This publicly-traded company’s shares outstanding now amounts to $93.73 million, simultaneously with a float of $88.26 million. The organization now has a market capitalization sitting at $11.66 billion. At the time of writing, stock’s 50-day Moving Average stood at $125.86, while the 200-day Moving Average is $111.44.
Sarepta Therapeutics Inc (SRPT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Sarepta Therapeutics Inc’s current insider ownership accounts for 5.96%, in contrast to 86.65% institutional ownership. According to the most recent insider trade that took place on Mar 11 ’24, this organization’s Director sold 761 shares at the rate of 122.93, making the entire transaction reach 93,550 in total value, affecting insider ownership by 7,516. Preceding that transaction, on Mar 08 ’24, Company’s Director sold 15,000 for 123.25, making the whole transaction’s value amount to 1,848,795. This particular insider is now the holder of 22,840 in total.
Sarepta Therapeutics Inc (SRPT) Earnings and Revenue Records
Sarepta Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 140.46% and is forecasted to reach 10.22 in the upcoming year.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Trading Performance Indicators
Let’s observe the current performance indicators for Sarepta Therapeutics Inc (SRPT). It’s Quick Ratio in the last reported quarter now stands at 3.45. The Stock has managed to achieve an average true range (ATR) of 3.72. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.38.
In the same vein, SRPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.16, a figure that is expected to reach 0.01 in the next quarter, and analysts are predicting that it will be 10.22 at the market close of one year from today.
Technical Analysis of Sarepta Therapeutics Inc (SRPT)
If we take a close look at the recent performances of Sarepta Therapeutics Inc (NASDAQ: SRPT), its last 5-days Average volume was 0.82 million that shows plunge from its year to date volume of 0.99 million. During the previous 9 days, stock’s Stochastic %D was recorded 44.17% While, its Average True Range was 3.81.
Raw Stochastic average of Sarepta Therapeutics Inc (SRPT) in the period of the previous 100 days is set at 70.85%, which indicates a major fall in contrast to 74.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 32.27% that was lower than 42.57% volatility it exhibited in the past 100-days period.
